These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 3258886)

  • 41. Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells.
    Itoh K; Tilden AB; Kumagai K; Balch CM
    J Immunol; 1985 Feb; 134(2):802-7. PubMed ID: 3917475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.
    Heo DS; Whiteside TL; Johnson JT; Chen KN; Barnes EL; Herberman RB
    Cancer Res; 1987 Dec; 47(23):6353-62. PubMed ID: 3315186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R; Nagler A
    Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells.
    Gerosa F; Tommasi M; Benati C; Gandini G; Libonati M; Tridente G; Carra G; Trinchieri G
    Cell Immunol; 1993 Sep; 150(2):382-90. PubMed ID: 8103709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased cytotoxicity and CD16 (Leu 11) expression in long-term, IL-2-activated human peripheral blood mononuclear cells.
    Podack ER; Penichet KO; Lin BY; Chiao JW; Mittelman A
    Blood Cells; 1987; 13(1-2):117-22. PubMed ID: 3311212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
    McCrady CW; Li F; Grant AJ; Merchant RE; Carchman RA
    Cancer Res; 1988 Feb; 48(3):635-40. PubMed ID: 3257170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural killer cell function and expression of beta 7 integrin in psoriatic arthritis.
    McQueen FM; Skinner MA; Krissansen GW; Robinson E; Tan PL
    J Rheumatol; 1994 Dec; 21(12):2266-73. PubMed ID: 7535357
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2.
    McMannis JD; Fisher RI; Creekmore SP; Braun DP; Harris JE; Ellis TM
    J Immunol; 1988 Feb; 140(4):1335-40. PubMed ID: 3257776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acquisition of non-MHC restricted cytotoxic function by IL 2 activated thymocytes with an "immature" antigenic phenotype.
    Phillips JH; Lanier LL
    J Immunol; 1987 Aug; 139(3):683-7. PubMed ID: 3110279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG; Martinson J
    Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell culture observations of human postnatal thymic epithelium: an in vitro model for growth and humoral influence on intrathymic T lymphocyte maturation.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1996; 10(5):515-26. PubMed ID: 8899432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells.
    Garni-Wagner BA; Purohit A; Mathew PA; Bennett M; Kumar V
    J Immunol; 1993 Jul; 151(1):60-70. PubMed ID: 8326140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
    Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S; Naruo K; Shiho O; Tsukamoto K
    Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
    Caligiuri M; Murray C; Buchwald D; Levine H; Cheney P; Peterson D; Komaroff AL; Ritz J
    J Immunol; 1987 Nov; 139(10):3306-13. PubMed ID: 2824604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of murine thymocytes with CD3-associated T-cell receptor structures.
    Bluestone JA; Pardoll D; Sharrow SO; Fowlkes BJ
    Nature; 1987 Mar 5-11; 326(6108):82-4. PubMed ID: 3102972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic and functional modulation of interleukin-2-activated peripheral blood mononuclear cells by anti-CD3 and anti-CD28 antibody.
    Yoshino I; Yano T; Miyamoto M; Sugimachi K; Kimura G; Nomoto K
    Lymphokine Cytokine Res; 1993 Aug; 12(4):191-6. PubMed ID: 8218591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
    Kaufmann Y; Levanon M; Davidsohn J; Ramot B
    J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
    J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.